Calcified intracranial lesions: detection with gradient-echo-acquisition rapid MR imaging

Seventeen patients with partially calcified intracranial lesions, as documented by CT, were evaluated with MR imaging at 1.5 T. All patients were imaged with both conventional spin-echo techniques and reduced flip-angle gradient-echo-acquisition (GEA) sequences, during which a signal is acquired in the absence of a 180 degrees radiofrequency pulse. GEA parameters were implemented so that T2* effects were maximized on these scans. In all 17 patients GEA images showed marked hypointensity throughout the entire area of calcification, matching the calcified region as seen on CT. In contrast, spin-echo findings in the calcified portions of the lesions were extremely variable, precluding confident identification of calcification on these images. The depiction of regions of calcification as marked hypointensity on GEA images can be ascribed to T2* shortening from static local magnetic field gradients at interfaces of regions differing in magnetic susceptibility, a phenomenon that is well documented in vitro, when various diamagnetic solids are placed in aqueous suspension. However, we cannot exclude the possible additional role of accompanying paramagnetic ions, which sometimes are present with diamagnetic calcium salts in various intracranial calcifications. Since the hypointensity due to calcification on GEA images is not specific, noncontrast CT could be used to confirm its presence. Although this lack of specificity and the artifacts that emanate from diamagnetic susceptibility gradients at or near air-brain interfaces somewhat limit the application of GEA techniques, we suggest that rapid MR imaging using GEA sequences can consistently demonstrate intracranial calcification, and that this technique thus seems to be a useful adjunct to conventional spin-echo imaging.     

Experimental hyaline cartilage lesions: two-dimensional spin-echo versus three-dimensional gradient-echo MR imaging.

The value of magnetic resonance (MR) imaging, with two-dimensional (2D) spin-echo and FISP (fast imaging with steady-state precession) and FLASH (fast low-angle shot) three-dimensional (3D) gradient-echo sequences, for the detection of hyaline cartilage defects of the femoral condyle and the tibial plateau, was investigated in an animal model. In eight dogs, the anterior cruciate ligament was transected in one knee joint, resulting in rapid development of osteoarthritis with degeneration of the hyaline cartilage. At autopsy, 24 cartilage lesions were found, which were classified into four grades. The overall detection of cartilage lesions with MR imaging was poor. Only five of the 24 lesions were visible on 2D spin-echo images, while 11 of 24 were visible on 3D FISP images and 15 of 24 were seen on 3D FLASH images. The best results were obtained in advanced stages of cartilage degeneration, involving ulceration and complete abrasion of the cartilage layer. Signal loss or signal intensity increase in the cartilage layer was seen inconsistently in grades 3 and 4 degeneration. In this animal model, 2D spin-echo imaging was inadequate for the diagnosis of hyaline cartilage lesions, while 3D gradient-echo imaging permitted satisfactory diagnosis in only grade 4 cartilage disease.     

MRI各序列诊断创伤性脑损伤的价值比较 MRI各序列诊断创伤性脑损伤的价值比较

目的：比较MRI各序列诊断创伤性脑损伤（traumatic brain injury,TBI）的价值.方法：对260例TBI患者行MRI序列组合扫描,包括FLASH、FLAIR、SE T1WI、TSE T2WI,分析不同类型TBI的影像特点,比较各序列对病灶的显示率.结果：260例中,FLASH显示244例（93.8％）,FLAIR显示249例（95.8％）,T2WI显示200例（76.9％）,T1WI显示199例（76.5％）,FLASH与FLAIR比较、T2WI与T1 WI比较,显示率差异均无统计学意义（P均＞0.05）;FLASH、FLAIR分别与T2WI、T1WI相比,显示率差异均有统计学意义（P均＜0.01）,FLASH、FLAIR对TBI病变的显示优于T2WI、T1WI.结论：MRI各序列显示TBI病灶总体敏感性由高至低依次为FLAIR、FLASH、T2WI、T1WI.FLAIR、FLASH应作为MRI诊断TBI的首选序列.     

Detection of acute and treated lesions of hepatosplenic candidiasis: comparison of dynamic contrast-enhanced CT and MR imaging.

Dynamic contrast-enhanced computed tomography (CT) was compared with 1.5-T magnetic resonance (MR) imaging with FLASH (fast low-angle shot), gadolinium-enhanced FLASH (Gd-FLASH), and T2-weighted fat-suppression (T2FS) sequences in 11 patients with hematologic malignancies, five with biopsy-confirmed hepatosplenic candidiasis treated with antifungal chemotherapy and six with a clinical history suggestive of acute hepatosplenic candidiasis. CT and MR images were separately interpreted in a prospective fashion. MR imaging showed lesions compatible with candidiasis in the liver in six patients, the spleen in five, and the kidneys in one. CT showed candidiasis-compatible lesions in the liver in three patients and the spleen in one; no renal lesions were shown. Differences between acute and treated candidal lesions were observed. Gd-FLASH images showed the most liver lesions (n = 106), followed by FLASH (n = 85), T2FS (n = 20), and CT (n = 18). MR imaging performed better than CT in distinguishing candidal hepatic lesions from recurrent lymphoblastic lymphoma in one patient and from hepatic infarcts in another. The results suggest that MR imaging may be superior to CT in detecting lesions of hepatosplenic candidiasis.     

Efficacy of nonionic low-osmolar gadodiamide injection in animals with intracranial mass lesions.

Gadodiamide injection is a nonionic, low-osmolar formulation of a paramagnetic metal chelate complex consisting of gadodiamide and caldiamide sodium. The efficacy of gadodiamide injection as a magnetic resonance (MR) imaging enhancement medium was evaluated by imaging intracranial 9L-glioma lesions induced in rats and naturally occurring lesions in dogs. T1- and T2-weighted spin-echo images were obtained before and after administration of gadodiamide injection at doses of 0.1 and 0.2 mmol/kg. On the precontrast T1-weighted images, the intracranial lesions were not well seen, appearing isointense to normal brain parenchyma. Although the presence of disease was shown unequivocally on the T2-weighted images, the margins of the masses could not be delineated. Postcontrast T1-weighted images were characterized by marked enhancement of the tumor, with no change in signal intensity in the surrounding edematous brain tissue. Gadodiamide injection was efficacious in identifying areas of blood-brain barrier breakdown associated with intracranial masses.     

Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging

The purpose of our study was to evaluate the potential value of ferumoxide-enhanced T1-weighted magnetic resonance (MR) imaging for tissue characterization of focal liver lesions when combined with T2-weighted sequences. Images were acquired within 30 minutes after the end of ferumoxide administration, when ferrite particles were not totally cleared from the intravascular compartment. Thirty-eight patients with 47 focal liver lesions underwent T1-weighted gradient-echo (TR/TE 150/4.1 msec) and T2-weighted fast spin-echo (3180-8638/90 msec) MR imaging at 1.5 T before and after intravenous administration of ferumoxides (10 micromol/kg body weight). A qualitative and quantitative analysis was performed. During the early phase after infusion of ferumoxide, blood vessels showed hypersignal intensity on T1-weighted fast low-angle shot (FLASH) images, while liver signal decreased. Hemangiomas showed both homogeneous and inhomogeneous enhancement patterns, and liver metastasis most typically showed ring enhancement. Hypervascular tumors (hepatocellular carcinomas and focal nodular hyperplasias) showed a slight degree of homogeneous enhancement. Quantitatively, the degree of enhancement and lesion-to-liver contrast on ferumoxide-enhanced images were significantly different among these tumors. Our results demonstrate that distinct enhancement patterns obtained on ferumoxide-enhanced T1-weighted MR imaging improve tissue characterization of focal liver lesions when combined with T2-weighted images.     

Susceptibility weighted imaging: Clinical applications and future directions

Susceptibility weighted imaging (SWI) is a recently developed magnetic resonance imaging (MRI) technique that is increasingly being used to narrow the differential diagnosis of many neurologic disorders. It exploits the magnetic susceptibility differences of various compounds including deoxygenated blood, blood products, iron and calcium, thus enabling a new source of contrast in MR. In this review, we illustrate its basic clinical applications in neuroimaging. SWI is based on a fully velocity-compensated, high-resolution, three dimensional gradient-echo sequence using magnitude and phase images either separately or in combination with each other, in order to characterize brain tissue. SWI is particularly useful in the setting of trauma and acute neurologic presentations suggestive of stroke, but can also characterize occult low-flow vascular malformations, cerebral microbleeds, intracranial calcifications, neurodegenerative diseases and brain tumors. Furthermore, advanced MRI post-processing technique with quantitative susceptibility mapping, enables detailed anatomical differentiation based on quantification of brain iron from SWI raw data.     

Malignant lesions of the liver identified on T1- but not T2-weighted MR images at 1.5 T

The authors reviewed their 21/2-year experience with a magnetic resonance (MR) imaging protocol for a 1.5-T MR imager that included T2-weighted fat-suppressed spin-echo, T1-weighted breath-hold gradient-echo, and serial dynamic gadolinium-enhanced T1-weighted gradient-echo imaging to identify histologic types of malignant liver lesions more apparent on T1- than on T2-weighted images. MR images of 212 consecutive patients with malignant liver lesions were reviewed. T2-weighted, T1-weighted, and dynamic contrast-enhanced T1-weighted images were examined separately in a blinded fashion. Seven patients demonstrated liver lesions (lymphoma [two patients] and carcinoid, hepatocellular carcinoma, colon adenocarcinoma, transitional cell carcinoma, and melanoma [one patient each]) on T1-weighted images that were inconspicuous on T2-weighted images. In all cases, the lesions were most conspicuous on T1-weighted images obtained immediately after administration of contrast agent. Histologic confirmation was present for all seven patients. The consistent feature among these lesions was that they were hypovascular, due either to a fibrous stroma or to dense monoclonal cellularity. These results suggest that in some patients with hypovascular primary neoplasms, the lesions may be identified only on T1-weighted images, and that immediate postcontrast T1-weighted images are of particular value in demonstrating lesions.     

The value of fast gradient-echo MR sequences in the evaluation of brain disease

One-hundred-fifteen patients thought to have intracranial disease were studied with various two-dimensional short repetition time, partial-flip-angle gradient-echo techniques: at 1.0 T, fast low-angle short (FLASH) at 10 degrees and 30 degrees and fast imaging with steady-state precession (FISP) at 60 degrees; at 1.5 T, FLASH 10 degrees, 30 degrees, and 60 degrees, FISP 60 degrees, and contrast-enhanced fast steady state at 60 degrees. These sequences were compared with a T2-weighted spin-echo sequence to determine the relative sensitivities of these techniques in detecting parenchymal lesions. Except for hemorrhagic lesions a substantial number of abnormalities were either not visible or poorly seen on the partial-flip-angle gradient-echo sequences. Minimizing echo time (6-9 msec) to decrease magnetic susceptibility effects did not improve lesion detection. Current usage of two-dimensional gradient-echo techniques for lesion detection is limited, except when calcification or hemorrhage is involved. Their utility may be expanded via the incorporation of three-dimensional techniques and IV contrast agents.     

Characterization of Focal Liver Lesions with Superparamagnetic Iron Oxide-Enhanced MR Imaging: Value of Distributional Phase T1-Weighted Imaging

Objective

To determine the potential value of distributional-phase T1-weighted ferumoxides-enhanced magnetic resonance (MR) imaging for tissue characterization of focal liver lesions.

Materials and Methods

Ferumoxides-enhanced MR imaging was performed using a 1.5-T system in 46 patients referred for evaluation of known or suspected hepatic malignancies. Seventy-three focal liver lesions (30 hepatocellular carcinomas [HCC], 12 metastases, 15 cysts, 13 hemangiomas, and three cholangiocarcinomas) were evaluated. MR imaging included T1-weighted double-echo gradient-echo (TR/TE: 150/4.2 and 2.1 msec), T2*-weighted gradient-echo (TR/TE: 180/12 msec), and T2-weighted turbo spin-echo MR imaging at 1.5 T before and after intravenous administration of ferumoxides (15 mmol/kg body weight). Postcontrast T1-weighted imaging was performed within eight minutes of infusion of the contrast medium (distributional phase). Both qualitative and quantitative analysis was performed.

Results

During the distributional phase after infusion of ferumoxides, unique enhancement patterns of focal liver lesions were observed for hemangiomas, metastases, and hepatocellular carcinomas. On T1-weighted GRE images obtained during the distributional phase, hemangiomas showed a typical positive enhancement pattern of increased signal; metastases showed ring enhancement; and hepatocellar carcinomas showed slight enhancement. Quantitatively, the signal-to-noise ratio of hemangiomas was much higher than that of other tumors (p < .05) and was similar to that of intrahepatic vessels. This finding permitted more effective differentiation between hemangiomas and other malignant tumors.

Conclusion

T1-weighted double-echo FLASH images obtained soon after the infusion of ferumoxides, show characteristic enhancement patterns and improved the differentiation of focal liver lesions.     

Dynamic MR imaging of human brain oxygenation during rest and photic stimulation.

Dynamic FLASH (fast low-angle shot) magnetic resonance (MR) imaging was used to monitor changes in brain oxygenation in the human visual cortex during photic stimulation. The approach exploits the sensitivity of the gradient-echo signal to susceptibility changes induced by varying concentrations of paramagnetic deoxyhemoglobin in the cerebral blood pool. After the onset of binocular photic stimulation (10 Hz, red light, checker-board), there was a distinct increase in the MR signal in the calcarine cortex within 6-9 seconds, indicating a decrease in the total deoxyhemoglobin concentration. After the stimulation was switched off, the MR signal returned to a basal value within a similar period of time. Assuming enhanced blood flow and only a minor increase in oxygen consumption (production of deoxyhemoglobin) during physiologic activation, the results reflect an enhanced supply of diamagnetic oxyhemoglobin and an increase in the partial oxygen pressure in the capillary and venous blood pools. In addition, a decrease in the basal MR signal in the calcarine cortex was observed during the first 60-90 seconds of persistent activation, which may be understood as an autoregulatory adaptation to increased overall brain activity associated with information processing due to continuous perception of visual stimuli.     

Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging

OBJECTIVE: The purpose of this study was to evaluate the diagnostic accuracy of ferumoxides-enhanced MR imaging for screening malignant hepatic lesions before orthotopic liver transplantation. MATERIALS AND METHODS: The study comprised 48 patients who underwent MR imaging within 6 months before transplantation. Imaging techniques included unenhanced and ferumoxides-enhanced T1-weighted gradient-echo and T2-weighted fast spin-echo sequences and ferumoxides-enhanced T2(*)-weighted gradient-echo sequences. Qualitative and quantitative analyses were performed; the gold standard was the histopathologic reports of explanted livers. RESULTS: Twenty patients had malignant hepatic lesions, and 24 hepatocellular carcinomas were histopathologically proven. The mean area under the receiver operating characteristic curve and the mean sensitivity were significantly greater for the image sets with ferumoxides-enhanced gradient-echo sequences than for those without these sequences. The mean sensitivity and specificity of all sequences were 85% and 74% on a per-patient basis, respectively. The mean contrast-to-noise ratio was significantly greater for the ferumoxides-enhanced T2(*)-weighted gradient-echo sequences than for any other sequences and for the ferumoxides-enhanced T1-weighted gradient-echo sequences than for unenhanced sequences and the ferumoxides-enhanced T2-weighted fast spin-echo sequences. CONCLUSION: Ferumoxides-enhanced gradient-echo sequences improved the diagnostic accuracy and the sensitivity for detecting malignant hepatic lesions in patients with end-stage cirrhosis of the liver. However, the specificity was not improved even after the administration of ferumoxides because of the false-positive lesions that were mainly the result of fibrotic changes.     

Vascular intracranial lesions: applications of gradient-echo MR imaging

To investigate the role of the gradient-echo (GRE) technique in clinical intracranial magnetic resonance (MR) imaging, 63 patients with a variety of vascular intracranial lesions were examined at 1.5 T with the use of spin-echo (SE) and GRE sequences. In all cases, the sequential section acquisition technique called gradient recalled acquisition in the steady state (GRASS) was employed; a repetition time of 150-200 msec, an echo time of 13-16 msec, and a flip angle of 50 degrees-60 degrees were used to optimize the depiction of blood flow as high intensity and the depiction of stationary fluid as low intensity. In 61 of 63 cases, gradient moment nulling was utilized to compensate for first-order flow effects. Although GRE images rapidly demonstrated flow in vascular intracranial lesions as high intensity, the vascular nature of these lesions was also clearly evident on SE images in most cases. In some cases, GRE images can be used to clarify the vascular nature of a lesion or to characterize a neoplasm. Other applications include the detection of vascular thrombosis, occult vascular malformations, and hemorrhagic complications of vascular lesions.     

Correlation of phase values with CT Hounsfield and R2* values in calcified neurocysticercosis

Purpose:

To correlate phase and R2* derived from susceptibility‐weighted magnetic resonance imaging (MRI) with computed tomography‐Hounsfield (CT‐HU) values in calcified neurocysticercosis and to evaluate phase imaging in the assessment of calcified neurocysticercosis.

Materials and Methods:

Thirty‐five patients with 52 calcified lesions underwent both CT and MRI. Phase and R2* were calculated from multi‐echo 3D‐T2‐star‐weighted‐angiography data. MRI and CT data were coregistered using mutual information. Spearman's correlation was performed between quantitative phase and CT‐HU and R2* values. The Mann–Whitney U‐test was used to see differences between CT‐HU and R2* values from corresponding positive and negative phase regions.

Results:

The median values of CT‐HU and R2* from regions with positive and negative phase were found to be 142.10 (range: 41.89–491.75) and 68.5/sec (range: 20–110/sec) and 137.30 (range: 30.83–458.88) and 69/sec (range: 0–110/sec), respectively. There was a significant correlation of positive phase values with corresponding CT‐HU and R2* values. In addition, there was a significant correlation of R2* and CT‐HU with negative phase values.

Conclusion:

We conclude that there is a significant correlation between negative and positive phase with CT‐HU and R2* values, suggesting that the CT hyperdense lesion may have both calcium and other minerals, which can be differentiated using phase imaging. Conventional MRI should include phase imaging to detect calcified neurocysticercosis. J. Magn. Reson. Imaging 2011;. © 2011 Wiley Periodicals, Inc.     

Identification of calcified intracardiac lesions using gradient echo MR imaging

Gradient echo signal imaging (GEI) has expanded the clinical role of magnetic resonance (MR) imaging of the heart. The role of GEI to evaluate intracardiac calcified lesions was studied. All patients were imaged with both conventional spin echo (SE) techniques and GEI. The GEI demonstrated that calcific cardiac lesions exhibit magnetic susceptibility differences and produce marked hypointensity throughout the calcified area. All patients had echocardiographic and fluoroscopic evidence of cardiac calcification and surgical confirmation of calcified lesions. The SE MR was unable to define the intracardiac calcification. Gradient echo imaging may be a helpful adjunct in the complete definition of intracardiac calcific lesions. When profound signal void areas are detected on cardiac GEI studies, calcification should be suspected.     

Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis]

Forty-four patients with small cell carcinoma of the bronchus underwent CT and MR studies of the brain to detect cerebral metastases. All patients were studied with contrast-enhanced CT scans, short (T1-weighted) and long (T2-weighted), spin-echo (SE) and FLASH 90 degrees MR sequences. Gd-DTPA enhanced SE-T1 and FLASH 90 degrees sequences were also obtained. A quantitative comparison of the results was carried out to assess the sensitivity of the different techniques in the detection of brain metastases according to lesion diameter. Metastases were identified in 19/44 patients (43%). All techniques detected the lesions greater than 2 cm; of the metastases less than 2 cm, 63/124 (51%) were detected only by Gd-DTPA SE-T1 and FLASH sequences and 11 more (9%) only by Gd-DTPA SE-T1 scans. All the lesions identified on enhanced CT scans or on T2-weighted images were easily detected by Gd-DTPA scans. CT sensitivity was higher than that of pre-contrast SE-T1 and FLASH studies and only slightly lower than that of T2-weighted images. As for lesions less than 2 cm, Gd-DTPA T1-weighted sequences had the highest detection rate (124 lesions) versus Gd-DTPA FLASH 90 degrees scans (113 lesions) and precontrast T1-weighted scans (45 lesions). When comparing Gd-DTPA SE-T1 and FLASH 90 degrees sequences in the detection of lesions less than 1 cm, we observed that the latter missed 9% of metastases, mainly due to a high rate of magnetic susceptibility artifacts and to lower contrast resolution. Therefore, Gd-DTPA SE-T1 images still remain the most accurate technique in the assessment of cerebral metastases.     

Magnetic resonance with marked T2-weighted images: improved demonstration of brain lesions, tumor, and edema

The object of this study was to determine the sensitivity of magnetic resonance (MR) for imaging intracranial lesions with heavily T2-weighted images compared with that of computed tomographic (CT) and T1-weighted images. Fifty-five patients with known intracranial pathology consisting of primary neurogenic tumors, brain infarcts, demyelinating disease, and metastases were studied by MR and CT. Patients were studied with either 0.6 or 1.5 T systems with T1- and T2-weighted radiofrequency pulse sequences. The heavily T2-weighted images were found to be superior to the T1-weighted images in terms of sensitivity, with 168 lesions found versus 86 by CT and 104 by T1-weighted imaging.     

Conspicuity of diffuse axonal injury lesions on diffusion-weighted MR imaging

OBJECTIVE: (1) To detect diffuse axonal injury (DAI) lesions by diffusion-weighted imaging (DWI), as compared with fluid-attenuated inversion recovery (FLAIR) imaging and (2) to evaluate hemorrhagic DAI lesions by b0 images obtained from DWI, as compared with gradient-echo (GRE) imaging. METHODS: We reviewed MR images of 36 patients with a diagnosis of DAI. MR imaging was performed 20 h to 14 days (mean, 3.7 days) after traumatic brain injury. We evaluated: (1) conspicuity of lesions on DWI and FLAIR and (2) conspicuity of hemorrhage in DAI lesions on b0 images and GRE imaging. RESULTS: DWI clearly depicted high-signal DAI lesions. The sensitivity of DWI to lesional conspicuity in DAI lesions was almost equal to that of FLAIR. The sensitivity of b0 images to identification of hemorrhagic DAI lesions was inferior to that of GRE. CONCLUSION: DWI is as useful as FLAIR in detecting DAI lesions. GRE imaging is still the superior tool for the evaluation of hemorrhagic DAI.     

Functional MR imaging using gradient-echo echo-planar imaging in the presence of large static field inhomogeneities

At 1.5 T, the field strength of most clinical MR imagers, gradient-echo Imaging Is the primary imaging method for measuring brain activation, as such sequences are highly sensitive to changes in blood oxygenation or T2* effects. Unfortunately, gradient-echo sequences are also extremely sensitive to magnetic field inhomogeneities, and this sensitivity has precluded examination of regions of cortex near field inhomogeneities with functional MR imaging. This article presents a gradient-echo echo-planar imaging method that uses variable amplitude scaling on the slice-select refocusing lobe to generate images compensated for static field inhomogeneities. A technique for constructing composite Images to be used in statistical tests for activation is also presented. The method is shown to produce clean activation maps in the presence of large static field inhomogeneities. The technique retains the sensitivity of gradient- echo imaging to changes in blood oxygenation while removing the sensitivity to large static field inhomogeneities.     

High-dose gadoteridol in MR imaging of intracranial neoplasms.

Twelve patients with a high suspicion of brain metastases by previous clinical or radiologic examinations were studied in a phase III investigation with magnetic resonance (MR) imaging at 1.5 T after a bolus intravenous injection of 0.1 mmol/kg gadoteridol followed at 30 minutes by a second bolus injection of 0.2 mmol/kg gadoteridol. All lesions were best demonstrated (showed greatest enhancement) at the 0.3-mmol/kg (cumulative) dose, with image analysis confirming signal intensity enhancement in the majority of cases after the second gadoteridol injection. More lesions were detected with the 0.3-mmol/kg dose than with the 0.1-mmol/kg dose, and more lesions were detected with the 0.1-mmol/kg dose than on precontrast images. In this limited clinical trial, high-dose gadoteridol injection (0.3-mmol/kg cumulative dose) provided improved lesion detection on MR images specifically in intracranial metastatic disease.